ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
62 680,94
-0,33%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. PROCEPT BioRobotics Corporation (PRCT)

  7. PROCEPT BioRobotics Corporation (PRCT) Actualités

PRCT PROCEPT BioRobotics Corporation

64,31
2,57 (4,16%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
PROCEPT BioRobotics Corporation PRCT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
2,57 4,16% 64,31 23:50:49
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
62,95 60,67 64,89 64,31 61,74
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202413:00GLOBEPROCEPT BioRobotics Reports First Quarter 2024 Financial..
29/4/202414:00GLOBELate Breaking Abstract Presented at the Japanese Urological..
23/4/202414:00GLOBEPROCEPT BioRobotics Announces 12 Scientific Research..
04/4/202422:04GLOBEPROCEPT BioRobotics Corp. Announces Investor Event at 2024..
02/4/202422:03GLOBEPROCEPT BioRobotics to Report First Quarter 2024 Financial..
08/3/202401:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202401:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202401:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202401:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:07EDGAR2Form 8-K - Current report
27/2/202422:02GLOBEPROCEPT BioRobotics Reports Fourth Quarter and Full Year..
13/2/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:05GLOBEPROCEPT BioRobotics to Present at the 44th Annual TD Cowen..
09/2/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202423:30GLOBECTS Corporation Announces Appointment of Amy M. Dodrill to..
08/2/202401:50EDGAR2Form 144 - Report of proposed sale of securities
08/2/202401:49EDGAR2Form 144 - Report of proposed sale of securities
11/1/202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202423:00GLOBEPROCEPT BioRobotics® Announces Preliminary Fourth Quarter..
16/12/202300:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202302:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202302:01EDGAR2Form 3/A - Initial statement of beneficial ownership of..
08/12/202323:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202301:27EDGAR2Form 144 - Report of proposed sale of securities
07/12/202301:05EDGAR2Form 144 - Report of proposed sale of securities
14/11/202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202300:29EDGAR2Form 144 - Report of proposed sale of securities
13/11/202322:03GLOBEPROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper..
02/11/202321:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202321:10EDGAR2Form 8-K - Current report
01/11/202321:02GLOBEPROCEPT BioRobotics® Reports Third Quarter 2023 Financial..
18/10/202322:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202322:05GLOBEPROCEPT BioRobotics to Report Third Quarter 2023 Financial..
12/10/202314:00GLOBEThe National Institute for Health and Care Excellence..
20/9/202314:00GLOBEPROCEPT BioRobotics Announces New Corporate Headquarters in..
12/9/202322:11EDGAR2Form 8-K - Current report
12/9/202314:00GLOBEPROCEPT BioRobotics® Receives U.S. FDA Investigational..
22/8/202314:00GLOBEPROCEPT BioRobotics® Announces First Commercial Aquablation..
17/8/202322:05GLOBEPROCEPT BioRobotics to Present at the 2023 Wells Fargo..
16/8/202314:00GLOBENorthShore University HealthSystem offers expanded access to..
04/8/202322:01EDGAR2Form 8-K - Current report
03/8/202322:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02/8/202304:10GLOBEPROCEPT BioRobotics Corporation Announces Pricing of Upsized..
01/8/202322:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
01/8/202322:06GLOBEPROCEPT BioRobotics Corporation Announces Proposed Offering..
01/8/202322:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
31/7/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
PRCT
PROCEPT BioRobotics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés